Product Code: 2687
Global Aesthetic Medicine Market is anticipated to experience robust growth through 2032, primarily due to the technological advancements associated with medical aesthetic devices. Besides, innovations in surgical and non-surgical aesthetic procedures such as fillers, photo rejuvenation, microdermabrasion, and cellulite therapies will positively impact the aesthetic medicine market growth.
Overall, the aesthetic medicine market is categorized on the basis of end-use, product, gender, type, and region.
Based on product, the market is likely to be driven by the energy-based segment. Energy-based aesthetic devices are chiefly used in minimally invasive procedures. Apart from the existing companies, new firms are also coming up with novel devices that impart aesthetic benefits with better efficacy and minimal invasion. These new devices have a range of applications such as hair removal, liposuction, scar treatment, non-surgical fat reduction, and body contouring. Increasing demand for such services is anticipated to drive market growth between 2023 and 2032.
In the context of type, the aesthetic medicine market is likely to be defined through the non-surgical segment, which will grow at a steady rate. The non-surgical treatments avert the complications and risks of traditional surgical treatments, enabling aesthetic improvements. Besides, non-surgical anti-aging procedures such as skin rejuvenation procedures and laser therapy are mostly suitable for the geriatric group as surgical treatments can have dire consequences such as delayed recovery time and procedural risks.
On the basis of end-use, the market is likely to be driven by the home settings segment. The segment churned out more than USD 2.2 billion revenue in 2022. There is an innate urge within the female population to look beautiful and young which, along with the growing belief that confidence and self-esteem are connected with aesthetic treatments, which will augment the market growth through the estimated timeframe.
Based on gender, the aesthetic medicine market is likely to be characterized by the female segment, which accounted for a higher market share in 2022 owing to increasing adoption of facial surgeries such as blepharoplasty, rhinoplasty, and breast augmentation procedures amongst women. Furthermore, surging technological advancements in non-invasive fat reduction procedures will further accelerate the market growth.
In the regional context, the aesthetic medicine market in Europe is expected to grow at a robust rate. The market in this region is anticipated to reach more than USD 9.2 billion by end of 2032. The driving factors behind the growth include the rapidly expanding rejuvenation centers, beauty centers, and aestheticians' offices.
Some of the key players, currently operating in the market include: Galderma, PhotoMedex, Merz Pharmaceuticals, Bausch Health Companies Inc., Allergan, Syneron Candela, Lumenis Inc., Alma Lasers, Johnson & Johnson, Cutera, Inc., and Cynosure.
Table of Contents
Chapter 1 Methodology
- 1.1 Industry coverage
- 1.2 Market scope & definitions
- 1.3 Base estimates & working
- 1.4 Forecast parameters
- 1.5 COVID-19 impact analysis at global level
- 1.6 Data validation
- 1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
- 1.7.2.1 Paid sources
- 1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Aesthetic medicine industry 360 degree synopsis, 2018-2032
- 2.1.1 Business trends
- 2.1.2 Type trends
- 2.1.3 Product trends
- 2.1.4 Gender trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends
Chapter 3 Aesthetic Medicine Industry Insights
- 3.1 Industry landscape, 2018- 2032 (USD Million)
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing awareness regarding aesthetic procedures
- 3.2.1.2 Technological advancements associated with medical aesthetic devices
- 3.2.1.3 Rising prevalence of obesity worldwide
- 3.2.1.4 Increasing adoption of non-invasive procedures
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost associated with aesthetic procedures
- 3.2.2.2 Lack of reimbursement and stringent regulatory scenario
- 3.3 Growth potential analysis
- 3.3.1 By type
- 3.3.2 By product
- 3.3.3 By gender
- 3.3.4 By end-use
- 3.4 COVID-19 impact analysis
- 3.5 Technology landscape
- 3.5.1 Microwave technology for hyperhidrosis
- 3.5.2 Ideal implants for breast augmentation
- 3.5.3 Nova threads technology and liquid facelift procedure
- 3.5.4 Laser-based vaginal rejuvenation
- 3.6 Regulatory landscape
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive landscape
- 4.1 Introduction
- 4.1.1 Galderma
- 4.1.2 AbbVie Inc. (Allergan)
- 4.1.3 Bausch Health Companies
- 4.2 Competitive dashboard, 2021
- 4.3 Company matrix analysis, 2021
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategic outlook matrix
Chapter 5 Aesthetic Medicine Market, By Type
- 5.1 Key segment trends
- 5.2 Surgical procedures
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3 Non-surgical procedures
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Aesthetic Medicine Market, By Product
- 6.1 Key segment trends
- 6.2 Energy based
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.2 Laser-based aesthetic device
- 6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.3 Radiofrequency (RF)-based aesthetic device
- 6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.4 Light-based aesthetic device
- 6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.5 Ultrasound aesthetic device
- 6.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.6 Others
- 6.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3 Non-energy based
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.2 Botulinum toxin
- 6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.3 Dermal fillers
- 6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.4 Implants
- 6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.4.2 Facial implants
- 6.3.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.4.3 Breast implants
- 6.3.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.4.4 Others
- 6.3.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Aesthetic Medicine Market, By Gender
- 7.1 Key segment trends
- 7.2 Male
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.2.2 18 years & below
- 7.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.2.3 19-34 years
- 7.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.2.4 35-50 years
- 7.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.2.5 51-64 years
- 7.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.2.6 65 years & above
- 7.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3 Female
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3.2 18 years & below
- 7.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3.3 19-34 years
- 7.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3.4 35-50 years
- 7.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3.5 51-64 years
- 7.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3.6 65 years & above
- 7.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Aesthetic Medicine Market, By End-use
- 8.1 Key segment trends
- 8.2 Hospitals
- 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 8.3 Ambulatory surgical centers
- 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 8.4 Beauty centers & medical spas
- 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 8.5 Dermatology clinics
- 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 8.6 Home settings
- 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Aesthetic Medicine Market, By Region
- 9.1 Key regional trends
- 9.2 North America
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
Chapter 10 Company Profiles
- 10.1 AbbVie Inc. (Allergan)
- 10.2 Alma Lasers
- 10.3 Cynosure
- 10.4 Galderma
- 10.5 Lumenis, Inc.
- 10.6 Johnson & Johnson
- 10.7 Merz Aesthetics
- 10.8 PhotoMedex
- 10.9 Syneron Candela
- 10.10 Cutera, Inc.
- 10.11 Bausch Health Companies, Inc.